FindTrial
Sign In

Effectiveness of Liquid Based Cytology (LBC) for Genetic Testing on Non-Small-Cell Lung Cancer

Effectiveness of Liquid Based Cytology (LBC) for Genetic Testing on Non-Small-Cell Lung Cancer - Effectiveness of Liquid Based Cytology (LBC) for Genetic Testing on Non-Small-Cell Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000016727
Enrollment
100
Registered
2015-03-25
Start date
2015-03-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary non-small-cell lung cancer

Interventions

None listed

Sponsors

Department of Thoracic Surgery, Kitasato University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Previously untreated non-small-lung cancer patients (2)The patients who are diagnosed as non-small-lung cancer before/during surgical operation (3)Regardless of age, gender, inpatient admission or outpatient (4)Written informed consent

Exclusion criteria

Exclusion criteria: (1)Small cell lung cancer patients (2)In case written informed consent is not obtained

Design outcomes

Primary

MeasureTime frame
Correlation of genetic testing between FFPE and LBC—

Countries

Japan

Contacts

Public ContactYukitoshi Satoh

Kitasato University Department of Thoracic Surgery

ysatoh@med.kitasato-u.ac.jp042-778-8828

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026